Thursday, August 20, 2026

Female ISIS Supporter Arrested in NY Bomb Plot

I was just watching the FBI press conference about this vile plot, and I'm sure we'll have to hear a lot of  the usual downplaying and gaslighting by the liberal media and the Democrats, and even sympathy by some people, before this terrorist is put on trial. Hearing this news a month before the 25th anniversary of September 11 somehow doesn't surprise me in the least.

Who knows? Maybe she'll become the latest criminal celebrity, like Luigi! 

------------------------------------------ 

New York Post 8-20-26

Female ISIS supporter caught in plot to bomb NY State Capitol building: FBI

By Vaughn Golden, Anthony Blair 

"An ISIS-inspired militant was arrested for allegedly plotting a deadly attack on the New York State Capitol in Albany, the FBI said Thursday.

"Jessica Bowie, 35, pledged allegiance to the Islamist terror group and began planning the attack in July, according to a criminal complaint obtained by ABC News.

"She allegedly purchased bomb materials from a hardware store on Aug. 5 and planned the attack with the help of FBI informants for two weeks, the feds said.

Jessica Bowie at a hardware store checkout with a shopping cart containing a large plastic bin of nails.

Jessica Bowie, 35, seen purchasing nails at a hardware store. US District Court Northern District of New York

A DoorDash delivery bag.

A DoorDash bag that was allegedly intended to hold the explosive device. US District Court Northern District of New York

"Bowie, who converted to Islam five years ago, also allegedly tracked the Capitol building for weeks, taking pictures from various vantage points including an “observation hall nearby,” according to the complaint.

"The FBI informants met Bowie Wednesday and gave her an inert explosive device and an inert handgun, along with instructions on how to detonate the bomb, the complaint said.

Jessica Bowie's reconnaissance photo of a building, showing reflective windows.

Bowie seen taking a photo on July 21, 2026 while she allegedly planned the terror attack at the Capitol. US District Court Northern District of New York

Circled picture of the New York State Capitol in Albany.

The Capitol circled in a photo taken by Bowie from an “observation hall” when she was allegedly planning the attack. US District Court Northern District of New York

The New York State Capitol in Albany, with a large fountain and green lawn in the foreground.

Jessica Bowie, 35, is accused of plotting to bomb the New York State Capitol building in Albany. Hans Pennink for NY Post

"She was soon arrested and appeared to offer a partial confession during her interview with FBI agents, according to the complaint.

“There’s no helping me, you guys know enough, there’s no helping me, I’m…going to prison for the rest of my life,” she allegedly said.

“Material support is up to 20 years in prison, I already Googled it before, I know I’m going to jail.”

COVID Is Rising

By Jen Christensen at CNN 8-20-26:

The traditional respiratory virus season hasn’t started, but Covid is already climbing

Are you coughing, hacking or feeling feverish? It may not be just a summer cold; you might want to consider taking a Covid test.

Although the autumn respiratory illness season hasn’t kicked off, and flu and RSV activity remain low, there’s a growing summer wave of Covid-19.

Case numbers aren’t especially high, and the United States isn’t recording many hospitalizations or deaths. But data from the US Centers for Disease Control and Prevention puts the test positivity rate for the week ending August 8 above 3% for the first time since March, with numbers climbing in every state.

“August is solidly Covid season,” said Dr. Caitlin Rivers, an expert in outbreak science and senior scholar at the Johns Hopkins Center for Health and Security. “Right now, the South and the West are sort of the leading edge of this Covid season. In the past, it almost always starts in Florida, Texas and Georgia, which is exactly what we’re seeing this year.”

Respiratory viruses circulate year-round in the United States, but waiting rooms typically fill with flu and RSV cases in the fall and winter. Since Covid joined the mix, coughing and sneezing season seems to be starting sooner.

Flu and RSV cases typically peak only once each year, between December and February, and taper off around April. Covid behaves differently, with winter and summer seasons. Experts say it’s a good time to take precautions.

How to stay aware

Tracking where Covid is spreading is a good first step toward avoiding illness, says Dr. Amanda Zink, an emergency room doctor in Alaska and a Yale University fellow who helped develop PopHIVE, a free platform for checking local and national health trends in the US that uses near real-time health data.

But tracking Covid cases has become trickier than it was during the height of the pandemic, when daily case counts were available on the CDC website. The federal government now collects far less data than it did during the pandemic. Labs no longer have to report negative tests, and hospitals no longer have to report specific bed capacity.

“We just have the tools we have,” said Dr. Scott Harris, state health officer for the Alabama Department of Public Health.

The CDC now relies on indicators including wastewater data, emergency room visits and lab results to gauge how much Covid is circulating in the country.

In Alabama, Harris says, Covid is not reflected in hospitalizations or mortality data yet, but cases are registering an “uptick” rather than a surge.

“It is going up,” Harris said Tuesday at a briefing held by the Association of State and Territorial Health Officials. “We don’t know how to describe these numbers that we’re seeing in terms of what the denominator is anymore.”

“Now we just know when we get a positive test, and we don’t even have clinical data sometimes to put that in context.”

Zink says that before traveling, people may want to consult PopHIVE and other disease tracking sites to help them decide what level of protection they want to bring with them.

“They can connect directly and say ‘what does the respiratory diseases look like in Kentucky?’ ” said Zink, who was chief medical officer for Alaska during the pandemic. “It can be helpful to know what’s out there, and then take the measures that you feel comfortable with and that you have the power to control.”

Amanda Bidwell, scientific program manager at WastewaterSCAN, a Stanford University-based program that monitors viruses and other germs in wastewater that updates daily, says she treats her website almost like a weather map before going out.

“I live in the Bay Area of California, and I’m able to look at my phone and be like, ‘Yep, Covid is taking off right now. I’m going to wear my mask if I’m going to go to this concert or going to get on a plane.’ ”

Wastewater data can also reveal where Covid or other diseases may worsen next, since people shed viral RNA days before they feel sick or get tested.

The CDC’s wastewater surveillance report says Covid is “very low” as of the week ending August 8. WastewaterSCAN, which uses different methodology and is more up to date, characterizes activity as “high.” It also detects an upward trend in the past 21 days in every region except the Midwest, where activity is “medium.”

With last-minute summer travel, the start of a new school year, and declining immunity from prior vaccination or infection, Covid cases will probably continue to rise.

Tracking case severity can also help you gauge your level of risk. The CDC’s analysis of emergency room data says that visits are low for Covid in many regions but increasing in the West and South as of August 12.

Preventing illness

Covid can still be serious and even deadly, so Zink reminds patients that there are non-pharmaceutical options to help keep them out of her emergency room in Palmer, Alaska.

Zink urges everyone to wash their hands regularly. The CDC suggests washing with soap and water for about 20 seconds, or about the time it takes to sing “Happy Birthday” twice.

A well-fitting N95 mask can filter at least 95% of airborne particles and help prevent you from breathing in the virus, as well as stopping you from spreading the virus if you are sick.

If you didn’t get a Covid vaccine last year, you may want to talk to your healthcare provider or pharmacist about getting one, maybe even the one that was formulated for last season, said Dr. James McDonald, commissioner of health for the New York State Department of Health.

“For people that are really at high-risk, for sure, if it’s been eight or 10 months since you’ve had the vaccine, I would say please talk to your provider about that,” McDonald noted, it’s not a black and white answer, but it’s important to find out what’s right for the individual based on their risk factors.

The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has made its suggestions for what should go into this season’s Covid shot. Experts expect it to start becoming available in late September, even though the CDC hasn’t officially recommended it.

Under the Trump administration, the federal government has shifted from a universal Covid vaccine recommendation to a more restricted one in which it’s recommended for everyone 6 months and over to consult with a healthcare provider. Most medical organizations recommend getting it, and insurance companies have indicated that they will continue to cover the shot.

If someone in your family gets sick or if you have close contact with someone with Covid, you might be able to take a new drug called Xocova, the first FDA-approved oral antiviral pill designed to help prevent illness in people 12 and older who are exposed to the coronavirus.

What to do if you get sick

If you get sick, Paxlovid can reduce your risk of developing a severe infection, particularly if you start taking the drug early after symptoms begin. But it’s no longer free, like it was during the pandemic, so check to see if your insurance covers it.

To help prevent the spread of illness, stay home when you have symptoms. The CDC recommends isolating and wearing a mask around others while symptoms continue.

When you’ve been fever-free without medication for 24 hours, the agency says, it’s safe to interact with others.

Tuesday, August 18, 2026

An Excellent Analysis of Wokeness/P.C. & The Dem Plot To Pretend It Never Happened

This is a great summing-up of the destruction that "wokeness" has caused. I remember back further when it was called "political correctness," and adherents found the word "Christmas" offensive and demanded it be changed to "Winter Holiday"; thought the phrase "master bedroom" evoked slavery; and wanted to eliminate "Mothers Day" and "Fathers Day" for not being "inclusive."  Even words like "manhole cover" and "mailman" were found objectionable. And it's only gotten worse.

The author writes, " Don’t let them trick you into thinking it was just an oopsie-daisy." I'm not fooled by them because I know they actually believe the nonsense they spout.  The author also says, "What — you don’t think they’re actually sorry for what they did, do you?" No, they aren't sorry at all. This is just a ploy to somehow make themselves look less radical to voters in time for the state and national elections.  It's like how Mamdani tried to make himself sound less antisemitic before he was elected - and then let loose with a vile speech after he unfortunately won.

George Orwell wrote in "1984': ""Every record has been destroyed or falsified, every book has been rewritten, every picture has been repainted, every statue and street and building has been renamed, every date has been altered."  The radicals have done this, too, and they will continual to do so when they are elected or reelected.

----------------------------------------------- 

 ‘Woke One’ Wasn’t Just Crazy — It Was Destructive

National Review, by Becket Adams, August 18, 2026 6:30 AM

"Don’t let them trick you into thinking it was just an oopsie-daisy.

"We’re living through a real-life attempt to erase the recent past.

“Woke One was crazy,” Representative Alexandria Ocasio-Cortez (D., N.Y.) laughed recently during an appearance on ABC News, approvingly quoting a New York City councilman. “Woke One was crazy. Okay, that’s a truth,” ABC’s Jonathan Karl replied. The anchor then asked whether the left had gone too far during “Woke One,” including with its calls to “defund the police.”

"This is where Ocasio-Cortez — and many within her ideological cohort, whether it’s writers at Vanity Fair or the New Republic, or New York City Mayor Zohran Mamdani, or even failed Wisconsin gubernatorial candidate Francesca Hong — want you to accept their version of events over your own memory.

“I think that during this time and during, especially during Covid, there was a huge opening of the Overton window,” Ocasio-Cortez said. “We were shut down. There was some of the highest unemployment rates that we have seen because of those shutdowns. And I think that the doors were really open in trying to entertain any and every policy that was going to get us to a better place. And I actually think that the discussions that were had in that time were quite fruitful.”

"She added, “I think that when we talk about crime today, it’s fundamentally different than the way that we talked about crime in bringing crime down, right? And I think that we all share in the goals of having as low a crime rate as possible. I think that, you know, during lockdown, of course, rhetoric in that time is not rhetoric that we would use today.” 

"Total nonsense.

"She’s simply trying to rewrite the record, and it’s as dishonest as it’s brazen. It’s also glaringly obvious what this is: a cleanup effort by someone with aspirations for higher office.

Your Local Epidemiologist:The Dose, 8-18-26

Here's Dr Katelyn Jetelina with another informative issue of "The Dose".

---------------------------------------- 

Covid-19 and dengue creeping up, vaccinations creeping down, a new mRNA flu vaccine, and more

The Dose (August 18)

As summer winds down, several diseases are winding up, like Covid-19 infections and rare mosquito-borne illnesses. Unfortunately, we can expect the same for vaccine-preventable diseases, according to new CDC data.

We also have some good news: the approval of a new mRNA flu vaccine. If you’re deciding whether to get it, there is some important nuance for you to consider.

Here’s your disease “weather report” and what it may mean for you and your family.


Disease weather report

Covid-19 wave is still small, but growing

Covid-19 levels (e.g., emergency department visits, wastewater transmission), remain low nationally but continue to rise in every state. The South and the West are the leaders, which is typical this time of year.

By the end of this wave, we can expect 10-15% of people to get infected. Thankfully, the number of hospitalizations isn’t nearly as high with population immunity, but Covid-19 remains serious for older adults, infants, and people who are immunocompromised.

Covid-19 wastewater levels. Source: Biobot.

Are Covid-19 metrics still useful for tracking waves? Yes, when used together. It’s true that fewer people and places are testing, but the positivity rate reflects the share of tests, which helps show the direction of trends. For wastewater, the number of sites has dipped slightly (from ~1,500 to 1,300), and funding is hanging on by a thread, but our systems still cover ~144 million people.

What this means for you: We are at the beginning of a Covid-19 wave. It’s not clear how small or big this will get, but if you’re high risk for severe disease, the time to get the vaccine is now.

Dengue cases creeping northward

It’s peak mosquito season. So rare mosquito-borne diseases like dengue (also known as “break-bone fever” due to severe joint pain) are popping up in the news, particularly in the Southern and Western U.S.

Last week, the first-ever non-travel-related case was reported in Virginia. A local mosquito bit a returning traveler with dengue, then bit another person nearby, and they got sick. This isn’t going to turn into an outbreak, because these mosquitoes only feed every few days, stay within a few hundred yards of where they hatched, and live just 2-4 weeks.

A few decades ago, epidemiologists would have been surprised to find locally acquired dengue in the U.S., as it was typically confined to the equator.

Mosquitoes in the U.S. have long been capable of carrying the disease (so infected mosquitoes aren’t marching northward from the equator), but the environment in the U.S. didn’t have conditions for the disease to thrive. Now, infected travelers combined with longer, warmer seasons create the perfect conditions for transmission. Scientists expect it to become increasingly common.

What this means for you: Dengue, or any mosquito-borne disease in the U.S., is very rare. Mosquitoes are mostly a nuisance. The name of the game is prevention of bites.

Vaccination rates continue to move backward

We can expect measles, whooping cough, and other vaccine-preventable diseases to continue to creep back up, according to CDC data released yesterday.

Some takeaways:

  1. Americans continue to vaccinate at high rates. The national MMR rate is 92.4%. (When was the last time that 92% of Americans agreed on something?) But all vaccines are decreasing by a tiny percent, and, in raw numbers, this means ~280,000 kindergarteners are unprotected.

  2. Exemption rates are climbing fast, though how fast varies widely by state. In Idaho, for instance, one in six kindergarteners is exempt from vaccines for religious or philosophical reasons. This is compared to near-zero rates in the five states, including California and West Virginia, that don’t allow such exemptions at all.

Vaccine exemptions in Idaho. Source: CDC.

What this means to you: The high national vaccination rates are great, but they mask state variability. And state rates mask local variability. Local rates (and unvaccinated, tight-knit pockets) are what really drive outbreaks, school disruptions, and costs to a county. This data is rarely available to parents and communities. I hope CDC is working on it, but in the meantime here is a tool from Washington Post to see where your community lands.


Spotlight on the new mRNA flu vaccine: The good, the not-so-great, and open questions

By now, you’ve probably seen the headlines: FDA approved the first mRNA flu shot (called mFlusiva) for older adults. Many people are excited about it. (It is great news!) Here is the nuance to help you make an evidence-based decision this fall.

The good: We needed better flu vaccines

In a large clinical trial, the mRNA flu vaccine was more effective than a standard vaccine at preventing symptoms in adults aged 50 and older: 2% of people who got mFlusiva developed flu, compared to 2.8% who got the standard shot. This equates to a 27% more effective vaccine.

This is good news because our standard flu vaccines aren’t that great at preventing infection. The flu virus mutates quickly, so flu vaccines can range from 15% to 60% effective each year, depending on how much the virus has changed over the 6 months it takes to make the vaccine and get it into arms. Any improvement is great. In addition, mRNA vaccine formulas can be updated in weeks, which would be enormous if we can adapt the annual policy pipeline to match that speed (or in case we get a flu pandemic).

The not-so-great: More side effects

If you’re like me and the mRNA Covid-19 vaccine knocked you out for a day or two, I have some unfortunate news: this one will probably do the same. That’s because, for some people, the immune system reacts to how mRNA vaccines are delivered into your cells (via lipid nanoparticles), leading to more inflammation.

Compared with a standard flu shot, the mRNA flu vaccine causes more injection-site pain (66% vs. 30%), fatigue (45% vs. 20%), and headaches (38% vs. 18%). Most of these side effects were mild and gone within a day or two, and no serious safety issues arose.

The open questions

1. How well does it work for seniors? It’s unclear.

For adults aged 50-64, the vaccine was fully approved because the clinical trial was straightforward: fewer people got sick.

For adults 65 and older, it’s messier. This group usually gets a high-dose flu shot, since their immune systems respond less strongly to a standard dose. But mFlusiva was never tested head-to-head against that high-dose shot in a clinical trial. Instead, it was approved for this age group based on high antibody levels tested in petri dishes. The mRNA flu vaccine has been shown to generate broader antibody responses than current vaccines, suggesting it could be more effective over time. The T cell response also seemed better. This will likely mean they are better, but we don’t have enough data yet to confirm this or answer “how much better?” FDA is requiring Moderna to run that head-to-head trial, but results won’t be in for a year or two. In the meantime, they authorized its use for people ages 65 and older through an accelerated approval.

2. Will people be able to get it this fall? Yes, maybe, I think?

For those aged 50-64, it’s unclear whether this will be widely available. Traditionally, ACIP has to recommend a new vaccine for insurance to cover it and for physicians to order it. But ACIP isn’t functioning because of a legal dispute between AAP and RFK Jr. It’s unclear what happens in fall.

For those 65 and older, there is a loophole: flu vaccine coverage under Medicare Part B is written directly into the law. It doesn’t depend on ACIP. That means people 65+ on Medicare should be able to get it this fall at no cost.

3. Will people actually get vaccinated?

This is the elephant in the room: flu vaccination rates are decreasing across the country at staggering rates. Shiny new biotechnology is cool, but not if people don’t use it.

What this means for you: A new mRNA flu vaccine should be available to those 65 years and older this fall.


Poll


Bottom line

Covid-19 is resurging, rare mosquito-borne diseases are gaining ground, and illnesses from the 19th century are making an unwelcome return. The tools to stop them exist (and new ones are coming), but the question is whether we’ll use them.

Love, YLE


Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members.

Dr Ruth Report, 8-17-26

Here's Dr Ruth Ann Crystal with another timely medical report.  As usual, she has compiled an impressive amount of helpful information. The high levels of COVID in the wastewater of certain states are staggering -- and frightening.

----------------------------------------------

Dr. Ruth Report, 8/17/26

The summer COVID wave has arrived, especially in the West and the South, as seen by increasing levels of SARS-CoV-2 virus in wastewater. We are starting from a lower baseline of COVID in wastewater with this wave.

Nationally, Emergency Department visits for COVID are very low, but are now increasing. Mike Hoerger estimates that on 8/8/26, every 1 in 144 people were infectious with COVID nationally, but there are hot spots, especially in the West and the South, where more people are sick with COVID now. For example, Dr. Hoerger estimated that as of 8/8/26, every 1 in 49 people in California were infected with COVID, although wastewater levels have increased since then.

The highest reported level of COVID in wastewater 8/16/26 on WastewaterSCAN was in Anchorage, AK where levels were an astronomical 10,450 PMMoV. New Orleans was at a whopping 862 PMMoV, Honolulu HI is at 382, Oceanside San Francisco at 351, San Rafael CA at 335, Pascagoula MS at 329 and Oakhurst NJ at 283 PMMoV.

KQED warns “Yes, That ‘Summer Cold’ Really Might Be COVID (Again). What to Know About Bay Area Viral Levels.”

Acute COVID infections, General COVID info

Divergent responses to SARS-CoV-2 infection reveal brain resilience-associated astrocyte programs in centenarians | Stem Cell Reviews and Reports Preprint 8/12/26

  • Scientists generated brain astrocytes from iPSC stem cells made from blood samples of centenarians (≥100 years) who had mild COVID and from younger adults under 45 who had critical illness. When infected with SARS-CoV-2, the centenarian astrocytes better controlled inflammation and showed fewer stress related protein changes, suggesting their astrocytes carry built in resilience against severe viral damage.

Vaccines

COVID vaccination may have prevented more than 4,000 deaths in one Washington county | CIDRAP 8/13/26

  • A new study shows that COVID vaccination may have prevented 20,000 severe outcomes and more than 4,000 deaths in one county in Washington state.

Antiviral treatments

The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants | JCI Insight 8/11/26 (David Ho’s lab)

  • Researchers from David Ho’s lab at Columbia University demonstrated in vitro that the monoclonal antibody VYD2311 from Invivyd successfully neutralized all seven recent SARS-CoV-2 variants evaluated, including XFG, NB.1.8.1, and BA.3.2.2. Across all variants tested, VYD2311 achieved neutralization at substantially greater potency than pemivibart (Pemgarda).

Organoid-based evaluation of [monoclonal antibodies] SA55 and Pemivibart against evolving SARS-CoV-2 variants | Emerging Microbes & Infection 8/3/26

  • Researchers from the University of Hong Kong tested two monoclonal antibodies against current SARS-CoV-2 subvariants in nasal organoids, finding that Pemivibart, the only FDA authorized antibody currently in use under Emergency Use Authorization, has lost 60 to 80 times its effectiveness against the XFG and KP.3.1.1 subvariants. Monoclonal antibody SA55 has retained strong potency and when delivered topically reduced SARS-CoV-2 viral load by more than 1,000 fold, suggesting it may offer a more durable option as the virus continues to evolve.

Long COVID

Multiomic and Spatial Profiling of Colorectal Tissue Reveals Viral Persistence and Immune Dysregulation in Long COVID | BioRxiV (UCSF) 8/10/26

An important new UCSF study of colorectal biopsies and blood from 44 people with Long COVID and 13 recovered controls found lingering SARS-CoV-2 RNA in 27% of Long COVID patients’ gut biopsies versus 7.7% of controls. The gut tissues with the viral remnants showed a skewed immune response with active innate inflammation, yet blunted adaptive clearance pointing to viral reservoirs that the immune system can sense, but cannot eliminate. The researchers identified 240 significantly altered genes in colorectal tissue biopsies, but only three in matched peripheral blood immune cells, suggesting that the pathophysiology of Long COVID may be compartmentalized within tissues and not within the blood.

Since the gastrointestinal tract is 25 to 30 feet long, random biopsy sampling may have missed areas of infected tissue in some patients. Small intestinal tissue turns over very quickly, so any virus seen on gut biopsy would most likely be related to a recent SARS-CoV-2 infection or seeding of the bowel.

The findings of this study support that in order to rid the body of viral reservoirs in gastrointestinal tissues in people with Long COVID, treatments may need to target both the persistent virus (with antivirals) and the immune dysfunction within tissues (with immune boosting medications).

Explainer article:

New Study Reveals Substantial Tissue-Level Immune Dysfunction Near Persistent Viral Reservoirs in Long COVID | PolyBio Research Foundation 8/11/26

  • It appears that there may be viral reservoirs of SARS-CoV-2 along the gastrointestinal tract in people with Long COVID that the immune system can see, but cannot eliminate. Using antiviral medication together with medications to boost immune response may be needed to help clear Long COVID.

Share

Virus reactivation in acute and long COVID-19 | Nature (Melamed) 8/5/26

  • A large IMPACC cohort study (1,154 hospitalized COVID-19 patients) found widespread reactivation of herpesviruses (EBV at the time of hospitalization and CMV a few weeks later) and Anelloviruses during acute COVID illness, tracking with severity and inflammation, even in immunocompetent patients. Reactivation persisted into convalescence, and Anellovirus transcripts were linked to Long COVID fatigue and physical disability, suggesting a possible biomarker.

Explainer article: COVID-19 can wake up dormant viruses in the body, large study confirms | Science 8/5/26

VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial | British J of Biomedical Science 7/27/26

  • Fondazione IRCCS Ca’ Granda in Milan enrolled 48 Long COVID patients in a randomized, placebo controlled trial finding that four weeks of high dose VSL#3 probiotic supplementation reduced fatigue in 68% of participants compared to 35.7% in the placebo group. Patients who responded to treatment also demonstrated measurable changes in gut microbiota composition and immune signaling markers.

👁️Subclinical neurovascular and immune correlates of post-COVID-19 syndrome detected by retinal imaging | Brain, Behaviour & Immunity- Health 8/6/26 “October 2026”

  • Researchers from Munich studied 128 participants and found that individuals with Long COVID showed measurable thinning of retinal nerve fiber layers alongside reduced macular volume compared to controls. Elevated levels of MCP-1, a protein associated with ongoing inflammatory activity, were specifically correlated with reduced thickness in the inner retinal layers, suggesting a detectable biological signature of post-COVID neurological involvement visible through eye imaging.

💪Persistent neuromuscular dysfunction in long COVID: A quantitative and single fiber EMG follow-up study | Clinical Neurophysiology 8/5/26

  • Danish scientists followed 50 Long COVID patients over approximately 1.4 years and found that myopathic EMG abnormalities dropped from 78% to 18% of participants. However, 56% of patients continued to show abnormal single fiber EMG (SFEMG) results alongside persistent fatigue, indicating that measurable neuromuscular dysfunction had not resolved even as some electrical markers improved. “Although SFEMG abnormalities persisted in the majority of patients, 40% showed normalization of objective neurophysiological parameters despite unchanged subjective fatigue symptoms, highlighting the discrepancy between electrophysiological recovery and patient-reported outcomes.”

🧠Identifying EEG biomarkers of fatigue and brain fog in long COVID: insights from rest and movement-related brain activity | J Clin Neurosci “Nov 2026” (8/12/26)

  • McGill University researchers studied 40 participants (20 Long COVID participants with fatigue, brain fog, and post-exertional malaise (PEM) vs. 20 age and sex-matched controls) and found a Long COVID signature on EEG. People with Long COVID displayed a reduced beta wave rebound following movement and a slower alpha rhythm at rest in the sensorimotor cortex, both of which signal compromised neural inhibition. These brain activity patterns corresponded directly to greater severity of fatigue and cognitive impairment in affected individuals.

    Share

🧠Long COVID affects working memory: assessment using a single rapid online test | Frontiers In Human Neuroscience 7/22/26

  • University of York scientists studied 1,064 participants and found that a Long COVID diagnosis was the single strongest predictor of reduced working memory performance. Patients who had been formally diagnosed with Long COVID scored lowest overall, and those who had experienced more SARS-CoV-2 infections showed progressively worse memory outcomes within that group.

🧠Neuropsychological consequences three years post-covid-19 are persistent and have great impact on everyday activities | Journal of Rehabilitation Medicine 8/3/26

  • Researchers from the University of Gothenburg followed 82 individuals recovering from COVID, with 59 completing testing at the three year mark. Standardized assessments showed ongoing impairments in attention, processing speed, and working memory, and 78% of participants still scored above the threshold for mental fatigue. These deficits pose substantial barriers to daily functioning and return to work, highlighting the need for targeted rehabilitation strategies.

🫀Changes in Subclinical Biomarkers of Myocardial Injury and Inflammation and SARS-COV-2 Serological Analyses in a Cohort of Community-dwelling Adults | Nature Preprint 7/29/26.

  • Johns Hopkins scientists tracked 607 adults and found that those with prior SARS-CoV-2 infection showed significantly greater increases in NT-proBNP, a biomarker indicating stress on the heart walls, over a six-month follow-up period. This elevation in cardiac strain was observed even among individuals who had experienced mild or asymptomatic infections, raising questions about cardiovascular consequences beyond severe hospitalized cases.

🦴Multiscale bone remodeling in COVID-19: from osteoimmune signaling to structural and mechanical impairment | Frontiers in Bioengineering and Biotechnology 7/21/26

  • Researchers at Politecnico di Milano reviewed emerging evidence on COVID and bone health. SARS-CoV-2 can weaken bone through both direct effects, such as inflammatory activation of bone-resorbing cells, and indirect pathways, including renin-angiotensin system disruption, corticosteroid exposure, and prolonged bed rest. Findings included reduced bone density, altered microarchitecture, and disrupted osteocyte signaling.

Effects of SARS-CoV-2 infection on femoral trabecular bone parameters in animal models: C) Time-course micro-CT imaging at 4-, 30-, and 60-day post-infection (dpi) illustrates progressive deterioration of trabecular structure in femur bone.

From: https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1812439/full

COVID-19 Associations With Thyroid Disease in Active-Duty Service Members: A Retrospective Cohort Study | Military Medicine 8/6/26

  • Uniformed Services University analyzed data from 687,531 matched adults and found that COVID infection was linked to a significantly elevated risk of newly diagnosed thyroid disease. Among active duty military personnel specifically, the hazard of developing thyroid conditions rose by 48%, with diagnoses typically appearing five to six months after infection.

Measles

CDC Measles Update

  • As of August 13, 2026, 2,566 confirmed measles cases were reported in the United States in 2026.

Johns Hopkins US Measles Tracker:

Ebola in Democratic Republic of Congo (DRC)

8/14/26 RDC update: “To date, 4,843 confirmed [Ebola] cases have been recorded. 777 patients are currently in isolation or hospitalized, 1,006 people have been cured since the start of the epidemic, and 2,272 deaths have been recorded. The case fatality rate stands at 46.9%, while the contact tracing rate reaches 83.2%.”

DR Congo Ebola outbreak on track to be largest in history | CIDRAP 8/12/26

  • WHO Director-General Tedros says DR Congo’s Ebola outbreak is on pace to surpass the 2014-16 West African outbreak, which killed over 11,000 people. WHO reports 4,449 confirmed cases and 2,061 deaths across five provinces in the current outbreak. Most deaths occur in the community, signaling unknown transmission chains and incomplete contact tracing, now at around 80%.

Cyclosporiasis

According to YLE, nationwide Cyclosporiasis cases have topped 20,000 this year, likely making this the largest foodborne outbreak on record, with counts still rising as Michigan investigators clear a case backlog. The contaminated lettuce appears cleared from circulation, though, as test positivity and emergency department visits have both declined sharply.

Salmonella in Jalapeños

A Salmonella outbreak linked to fresh jalapeños from Sinaloa, Mexico has sickened 345 people across 27 states, with 36 hospitalized and two antibiotic-resistant cases. Salmonella causes diarrhea, fever, and stomach cramps. Symptoms start 6 hours to a few days after eating contaminated food and may last for 4 to 7 days. Chipotle, Qdoba, and several prepared-food brands have recalled affected products. It may be best to avoid purchasing jalapenos, and associated foods like fresh salsas, until this salmonella outbreak is under control.

Share

Government Health News

Trump wants MMR vaccine split up: the science behind why it’s a bad idea | Nature 8/12/26

As measles outbreaks grow across the United States, President Trump issued an executive order on 8/10/26 pushing states to recommend splitting the MMR vaccine into three separate shots at separate appointments, an option which is not even currently available. Years of evidence have confirmed that the MMR vaccine is safe and effective as given.

Splitting the vaccine would mean more doctor visits, and studies show this lowers full vaccination rates, especially among lower income families, leaving those communities more vulnerable. The order will not actually change CDC recommendations or, likely, insurance coverage. Its main effect will be to sow further confusion about vaccines.

Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis | Lancet 7/19/26

  • “USAID funding has significantly contributed to the reduction in adult and child mortality across low-income and middle-income countries over the past two decades. Our estimates show that, unless the abrupt funding cuts announced and implemented in the first half of 2025 are reversed, a staggering number [14 million additional deaths, including 4.5 million children] of avoidable deaths could occur by 2030.”

Other news

UK records hottest day of the year as fifth heatwave reaches 38.1C [100.6F] peak

Diagnosis of Celiac Disease | JAMA 8/12/26

  • “JAMA Insights: For selected patients with Celiac Disease, serology may support diagnosis, but biopsy remains important for patients with immunoglobulin A deficiency, alarm symptoms, or certain autoimmune or chromosomal disorders.”

CAR T cell therapy beyond cancer: current status, challenges and future prospects | Signal Transduction and Targeted Therapy 8/11/26

  • Researchers are investigating whether CAR-T cell therapy can be repurposed to eliminate two categories of disease sustaining cells: viral reservoir cells that harbor latent infections and autoreactive B cells or plasma cells that drive autoimmune conditions. The goal is a lasting biological reset of the immune system rather than ongoing symptom management.

Antigen presentation at the blood–brain barrier amplifies neuroinflammation | Trends in Immunology 8/6/26

  • A review from UCSD shows that inflamed blood vessels in the brain can display antigens directly to CD8 T cells, extending the duration of contact between those immune cells and the blood–brain barrier and causing barrier damage in the process. This mechanism appears to stoke existing neuroinflammation rather than initially trigger it.

Weight-loss-independent actions of GLP-1 medicines | Cell Metabolism 8/4/26

  • A new Cell Metabolism study reveals that GLP-1 receptor agonists deliver measurable benefits to the heart, liver, kidneys, blood vessels, and immune system through direct biological pathways that operate separately from any reduction in body weight. These medicines appear to activate neural circuits, local organ receptors, and cross-organ signaling networks that collectively improve glucose regulation, blood pressure, and inflammatory responses across multiple body systems.

From: https://www.cell.com/cell-metabolism/fulltext/S1550-4131(26)00279-2

Vaccines to intercept colon cancer before it takes root are in the testing stage | LA Times 8/13/26

  • Scientists at MD Anderson Cancer Center and sites in Britain are testing vaccines designed to intercept colon cancer in people with Lynch syndrome, an inherited mutation affecting about 1 million Americans, before tumors form. Three candidate vaccines are in early trials, with a larger study expected to begin next year.

Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance | Science Translational Medicine 8/5/26

  • A clinical study of 15 peanut allergic adults found that fecal microbiome transplants (FMT) enabled 6 participants to tolerate greater peanut exposure than before treatment. Mechanistic work in mice revealed that Bacteroides species drive bile acid metabolism to elevate regulatory T cells, and this pathway was necessary for the observed protection against allergic response.

‘It just makes sense!’: 13-year old builds 3D printed wheelchair for 21 month old girl | ABC4 8/4/26

  • Thirteen year old Zac Waters of Lehi, Utah spent 300 hours this summer designing, 3D printing, and assembling a custom wheelchair for a 21 month old girl, using a design from the nonprofit MakeGood. The chair features pink accents, a removable tray table, and adjustable straps and footrest for comfort as she grows.

Photo by ABC4

Have a good week,

Ruth Ann Crystal MD